Dr. Debraj Shome
Consultant plastic Surgeon and head, Institute of Aesthetic Surgery, Apollo Hospitals, Hyderabad and eye cancer expert was recently chosen for the esteemed Colonel Rangachari Gold Medal Award and the Hanumantha Reddy Award for a year 2010 at the annual conference of all Indian Ophthalmological society. Dr Debraj Shome is the youngest ever recipient of this Award which bears testimony to the exceptional work being done by him.
Dr. Debraj Shome is also the first Indian recipient of the Davies foundation Grant Award by the Royal College of Surgeons, Glasgow, UK. This is awarded to two physicians every year for physicians who have performed sterling work in cancer research and therapy and have contributed to life saving research.
Raj Shankar in conversation with Dr. Debraj Shome…
HI: How different was your research and finding on eye cancer from that of other researchers and doctors ?
Dr. Debraj Shome: Radically different clinical trials have already demonstrated the efficacy of intra venous {injected thru blood steam} carboplatin therapy in the management of retinoblastoma {RB}. Systemic chemotherapy coupled with appropriate focal therapy has become a current standard of care in the management of these eye tumours. However, systemic chemotherapy is associated with its own risks. The regiments currently used can cause transient neutropenia , anemia and thrombocytopenia that may require blood product transfusion s, and organ toxicities including ear toxicity, kidney toxicity and liver toxicity. This is especially true in children as many children even die not from cancer per se but from the drugs injected.
We have actually started “local” injection of carboplatin around eye so that damage to the normal cell of the body is negligible!
For more information refer the link –
